ALCAM and myeloid sarcoma: For example, urinary ALCAM is a non-invasive biomarker of lupus nephritis; increased epithelial ALCAM expression supports T cell transmigration, and ALCAM expressed on B cell can navigate pathogenic B cells into the brain lesion of patients with multiple sclerosis (MS) (18–20).